Proteomic analysis of formalin-fixed prostate cancer tissue

Brian L. Hood, Marlene M. Darfler, Thomas G. Guiel, Bungo Furusato, David A. Lucas, Bradley R. Ringeisen, Isabell A. Sesterhenn, Thomas P. Conrads, Timothy D. Veenstra*, David B. Krizman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

236 Scopus citations


Proteomic analysis of formalin-fixed paraffin-embedded (FFPE) tissue would enable retrospective biomarker investigations of this vast archive of pathologically characterized clinical samples that exist worldwide. These FFPE tissues are, however, refractory to proteomic investigations utilizing many state of the art methodologies largely due to the high level of covalently cross-linked proteins arising from formalin fixation. A novel tissue microdissection technique has been developed and combined with a method to extract soluble peptides directly from FFPE tissue for mass spectral analysis of prostate cancer (PCa) and benign prostate hyperplasia (BPH). Hundreds of proteins from PCa and BPH tissue were identified, including several known PCa markers such as prostate-specific antigen, prostatic acid phosphatase, and macrophage inhibitory cytokine-1. Quantitative proteomic profiling utilizing stable isotope labeling confirmed similar expression levels of prostate-specific antigen and prostatic acid phosphatase in BPH and PCa cells, whereas the expression of macrophage inhibitory cytokine-1 was found to be greater in PCa as compared with BPH cells.

Original languageEnglish
Pages (from-to)1741-1753
Number of pages13
JournalMolecular and Cellular Proteomics
Issue number11
StatePublished - Nov 2005
Externally publishedYes


Dive into the research topics of 'Proteomic analysis of formalin-fixed prostate cancer tissue'. Together they form a unique fingerprint.

Cite this